FCMI
ORTX

Foresite Capital Management IV’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Foresite Capital Management IV’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-55,770
Closed -$6.63M – 16
2019
Q3 		$6.63M Buy
+55,770
New +$7.78M 2.14% 14
2019
Q1 		– Sell
-66,836
Closed -$10.5M – 18
2018
Q4 		$10.5M Buy
+66,836
New +$9.96M 4.83% 10

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Foresite Capital Management IV's ORTX Position: Q4 2019 in Review

Foresite Capital Management IV sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2019, closing a stake of 55,770 shares — an estimated $6.63M sold.

Foresite Capital Management IV first reported a position in ORTX in Q4 2018 and held it in 2 quarters. The position peaked at $10.5M in Q4 2018. 81 funds tracked by Wall St. Rank hold ORTX as of Q4 2019.

  • Foresite Capital Management IV reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Foresite Capital Management IV sold 55,770 Orchard Therapeutics plc American Depositary Shares shares in Q4 2019, an estimated $6.63M.
  • Foresite Capital Management IV first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 2 quarters.
  • Foresite Capital Management IV's Orchard Therapeutics plc American Depositary Shares position peaked at $10.5M in Q4 2018.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2019.

Based on Foresite Capital Management IV's 13F filing for Q4 2019, filed 14 Feb 2020.